Fresnais, M.; Roth, A.; Foerster, K.I.; Jäger, D.; Pfister, S.M.; Haefeli, W.E.; Burhenne, J.; Longuespée, R.
Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay. Cancers 2020, 12, 1897.
https://doi.org/10.3390/cancers12071897
AMA Style
Fresnais M, Roth A, Foerster KI, Jäger D, Pfister SM, Haefeli WE, Burhenne J, Longuespée R.
Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay. Cancers. 2020; 12(7):1897.
https://doi.org/10.3390/cancers12071897
Chicago/Turabian Style
Fresnais, Margaux, André Roth, Kathrin I. Foerster, Dirk Jäger, Stefan M. Pfister, Walter E. Haefeli, Jürgen Burhenne, and Rémi Longuespée.
2020. "Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay" Cancers 12, no. 7: 1897.
https://doi.org/10.3390/cancers12071897
APA Style
Fresnais, M., Roth, A., Foerster, K. I., Jäger, D., Pfister, S. M., Haefeli, W. E., Burhenne, J., & Longuespée, R.
(2020). Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay. Cancers, 12(7), 1897.
https://doi.org/10.3390/cancers12071897
